Category: BA.5
Denmark: BA.5 up 135% in a month
The latest weekly epidemiological file for Denmark has just been published. More...
Long Covid: Lingering cough more common in Omicron patients
Patients suffering from COVID-19 after-effects were more likely to have persistent coughs and fatigue if they were infected with the Omicron variant instead of the Delta or other strains, a survey showed. More...
Preprint: Enhanced Fusogenicity of BA.4, BA.5 and BA.2.12.1
“We found that the new Omicron subvariants BA.4/5 and BA.2.12.1 were more resistant to neutralization by mRNA-vaccinated and boosted health care worker sera and Omicron-BA.1-wave patient sera than were the BA.1 and BA.2 variants.” More...
Europe: BA.4 and BA.5 reclassified as Variants of Concern
The European Centre for Disease Prevention and Control has issued an Epidemiological update on 13th May 2022. More...
UK: 1,880 cases of XE Covid recombinant sequenced
The UKHSA have released a new technical briefing outlining the SARS-CoV-2 variants circulating in Britain. More...
South Africa: Covid-19 cases, hospitalizations and deaths rise in fifth wave
In a new report out today, an estimation of the current RO number in South Africa was revealed, along with evidence of increasing numbers of cases, hospitalizations and deaths across the country. More...
South Africa: Covid-19 remains a threat, we cannot just let the virus spread
“Our message remains again, to say that, Covid-19 remains a threat, it’s not over, and we cannot afford to drop all the prevention measures. More...
USA: BA.2.12.1 has transmission advantage of ~25% over BA.2 – *1 UPDATE*
CDC: “BA.2.12.1 might have a transmission advantage of about 25% over the BA.2 sub variant… The BA.2.12.1 sub variant makes up nearly 30% of sequences identified nationally.” More...
South Africa: BA.4 and BA.5 increasing as a proportion of sequenced cases *1 UPDATE*
An increasing share of South Africa’s Covid-19 cases are the BA.4 and BA.5 sub-lineages of the Omicron variant, suggesting those might have a growth advantage over others, Prof Helen Rees said on Thursday. More...